Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · August 10, 2017

Long-Term Outcomes With Anti-VEGF Therapy in Exudative Age-Related Macular Degeneration

Retina (Philadelphia, Pa.)

 

Additional Info

Retina (Philadelphia, Pa.)
Outcomes of Patients With Exudative Age-Related Macular Degeneration Treated With Antivascular Endothelial Growth Factor Therapy for Three or More Years: A Review of Current Outcomes
Retina (Philadelphia, Pa.) 2017 Jun 30;[EPub Ahead of Print], VL Qin, J Young, FQ Silva, FF Conti, RP Singh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading